75岁及以上男性铥激光前列腺剜除术的结局是否不同?一项倾向性评分分析
该回顾性研究纳入412例接受整块铥激光前列腺剜除术(ThuLEP)的男性,其中129例年龄≥75岁(组2)。经倾向性评分匹配后206例,两组中位手术时间55分钟、导尿2天、住院3天相似;总体85.9%无并发症(组1 82.5% vs 组2 89.3%),Clavien III-IV级并发症发生率相当(组1 3.8% vs 组2 1%)。术后1年IPSS、Qmax、QoL及再手术率组间无统计学显著差异。结论认为整块ThuLEP对≥75岁男性安全有效。
要点
- ≥75岁男性行整块ThuLEP,中位手术时间55分钟、导尿2天、住院3天,与年轻组相似。
- 总体85.9%无并发症,组1 82.5% vs 组2 89.3%;Clavien III-IV级并发症组1 3.8% vs 组2 1%。
- 术后1年IPSS、Qmax、QoL及再手术率组间无统计学显著差异。
核心结论
- 整块ThuLEP对≥75岁男性而言是安全有效的治疗。
研究设计与样本
- 回顾性评估412例接受整块ThuLEP的男性,其中129例年龄≥75岁(组2)。
- 纳入标准为药物治疗无效的下尿路症状、最大尿流率(Qmax)≤15 mL/s、国际前列腺症状评分(IPSS)≥8及手术绝对指征。
- 采用倾向性评分匹配,通过以年龄组为因变量的逐步逻辑回归模型估计组间差异,共匹配206例患者。
主要发现
- 组1平均年龄65.6±6.0岁,组2平均年龄79±3.7岁。
- 两组中位手术时间、导尿时间和住院时间相似(55分钟、2天和3天)。
- 总体85.9%的男性无并发症,组间无差异(组1 82.5% vs 组2 89.3%)。
- Clavien III-IV级并发症发生率相当(组1 3.8% vs 组2 1%)。
- 术后1年,两组IPSS、Qmax、QoL或再手术率无统计学显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the outcomes of thulium laser enucleation of the prostate (ThuLEP) in men aged ≥75 years compared to youngers. Traditional surgery has increased and significant morbidity in older men. Lasers have been introduced as an alternative approach to overcome the morbidity of traditional surgery. MATERIAL: We retrospectively evaluated 412 men who underwent en bloc ThuLEP. Inclusion criteria were lower urinary tract symptoms refractory to medical therapy, maximum urinary flow rate (Qmax) ≤15 mL/s, International Prostate Symptom Score (IPSS) ≥8 and absolute indications for surgery. Prostate volume, prostate specific antigen, IPSS, and Qmax, antiplatelet/anticoagulant therapy, ASA score, operation time, length of catheterization, discharge day, early complications, and reoperations were gathered. Differences between groups were estimated using propensity scores, by fitting a stepwise logistic regression model with age group as the dependent variable. RESULTS: One hundred twenty-nine patients were aged ≥75 years (Group 2). Mean age was 65.6 ± 6.0 years in Group 1 and 79 ± 3.7 years in Group 2. Propensity scores retrieved 206 patients. Median operation, catheterization time, and hospital stay were similar in both groups (55 minutes, 2 and 3 days). Overall, 85.9% of men had no complications, with no differences between the groups (82.5% in Group 1 and 89.3% in Group 2). The incidence of Clavien grade III-IV complications was comparable (3.8% in Group 1, 1% in Group 2). By 1 year, there were no statistically significant differences in IPSS, Qmax, QoL, or reoperation rate between the groups. CONCLUSION: En bloc ThuLEP is a safe and effective treatment even in men aged ≥75 years old.
引用
- Castellani D, Pirola GM, Gasparri L, et al. Are Outcomes of Thulium Laser Enucleation of the Prostate Different in Men Aged 75 and Over? A Propensity Score Analysis. Urology. 2019. PMID: 31252003. doi:10.1016/j.urology.2019.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。